Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort.
about
Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disordersTranscriptome sequencing of neurologic diseases associated genes in HHV-6A infected human astrocyte.A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology.The Relationship between Markers of Inflammation and Degeneration in the Central Nervous System and the Blood-Brain Barrier Impairment in Alzheimer's Disease.YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer's Disease.Neuronal Pentraxin 2 predicts medial temporal atrophy and memory decline across the Alzheimer's disease spectrum.Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer's disease and other neurodegenerative diseases.Biomarkers for the Early Detection and Progression of Alzheimer's Disease.Effect of carotid endarterectomy on brain damage markers.Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer's Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment.Immediate initiation of cART is associated with lower levels of cerebrospinal fluid YKL-40, a marker of microglial activation, in HIV-1 infection.Effect of physical exercise on markers of neuronal dysfunction in cerebrospinal fluid in patients with Alzheimer's disease.YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias.A meta-analysis of cerebrospinal fluid visinin-like protein-1 in alzheimers disease patients relative to healthy controls and mild cognitive impairment patients.A novel method for the rapid detection of post-translationally modified visinin-like protein 1 in rat models of brain injury.A Heparin Binding Motif Rich in Arginine and Lysine is the Functional Domain of YKL-40.Atherosclerosis is exacerbated by chitinase-3-like-1 in amyloid precursor protein transgenic mice.Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease.Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease.Amsterdam Dementia Cohort: Performing Research to Optimize Care.Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's diseaseQuestions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer's diseaseCSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer diseaseYKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
P2860
Q26741861-B7A0804B-DAC0-4E44-BD8C-4E45B5065520Q37565386-8713E07F-4C83-4F98-BF82-2CAB761C145AQ37648226-54B4BB94-EE6F-4450-982A-A323F21E0DF0Q38683919-C6A5FC89-5B52-4D65-8E35-B0FECA9A87DBQ38759253-C108A834-87D6-45F4-AA68-B3DC9EB7C3EBQ38839061-4213D946-AC8D-4732-AADF-A9CA48FABB18Q38915171-5BC8BA45-15D3-455E-860F-267D9BE15C43Q38979999-360078B6-42F7-41F6-A76B-2F2A5C1E8A9DQ39811657-B2F6D00B-159C-4DF7-AD0F-9DD6BAEAD20DQ40032161-CBD9E74D-F396-471C-BC76-C7E279F8BCD2Q40461425-0131E7DA-62FA-48BA-8C17-EFA47A0E4BD0Q42655670-01BD05CC-D446-4ADD-9B82-70480306DC2CQ45811351-67F50502-C452-4C3D-AED2-FBD4557858B6Q47141209-E8859059-6B45-42E9-B221-9B1CF4B5274EQ47250022-4D00B5D5-6BF5-4B9F-A743-069B829C9361Q47254535-E3A40084-3081-4489-AA83-B24695B4C11CQ47855094-2F71E862-E48A-4149-9BFC-DF8A349BC897Q51154144-93F7BB00-C767-4495-9122-C9C89727D89FQ52630015-A984398C-5676-4CF6-8082-67550D455759Q52644592-5561F071-6259-4961-B866-BE12C650DA46Q57493750-3792C2CE-D9FE-4318-990C-92008CC52A75Q57800439-D437D318-C898-4558-BB40-38BF8C3BB81BQ58697672-01F8F8D0-407B-4424-B262-6FDA69E4F4DBQ58742056-7E71F080-C857-4722-8881-EBD260301B02
P2860
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cerebrospinal fluid VILIP-1 an ...... ase in a memory clinic cohort.
@ast
Cerebrospinal fluid VILIP-1 an ...... ase in a memory clinic cohort.
@en
type
label
Cerebrospinal fluid VILIP-1 an ...... ase in a memory clinic cohort.
@ast
Cerebrospinal fluid VILIP-1 an ...... ase in a memory clinic cohort.
@en
prefLabel
Cerebrospinal fluid VILIP-1 an ...... ase in a memory clinic cohort.
@ast
Cerebrospinal fluid VILIP-1 an ...... ase in a memory clinic cohort.
@en
P2093
P2860
P50
P921
P1476
Cerebrospinal fluid VILIP-1 an ...... ase in a memory clinic cohort.
@en
P2093
Chengjie Xiong
Courtney Sutphen
Elizabeth M Herries
Jack H Ladenson
Maartje I Kester
P2860
P2888
P356
10.1186/S13195-015-0142-1
P407
P50
P577
2015-09-17T00:00:00Z
P5875
P6179
1000470049